India's Pivotal Role in the Evolving Global Pharma Landscape
Union Minister J P Nadda emphasizes India's strategic position in the changing global pharmaceutical scene, advocating for enhanced R&D, investment, and industry involvement. The government aims to foster innovation and support the sector through initiatives like Biopharma SHAKTI, strengthening domestic production and focusing on advanced medicines.
- Country:
- India
India is poised to become a leading force in the global pharmaceutical industry, as outlined by Union Minister J P Nadda during the India Pharma 2026 event. The minister highlighted India's growing emphasis on biologics, biosimilars, and specialty medicines, positioning it as a frontrunner in the evolving landscape.
Minister Nadda underscored the importance of increasing investment, enhancing R&D, and fostering industry collaboration. Initiatives such as Biopharma SHAKTI, with significant funding, demonstrate the government's support to transition India towards high-value pharmaceutical innovation.
Additionally, Minister of State Anupriya Patel announced plans to reform CDSCO and expand the scientific workforce, emphasizing the use of AI in drug discovery. Efforts to reinforce local manufacturing aim to build resilient supply chains, marking India as a preferred destination for drug development.
ALSO READ
-
Indian team to visit Washington for trade talks from Apr 20: Additional Secretary Darpan Jain.
-
Booming Demand: Summer Heats Up Indian Soft Drink Market
-
India's imports in 2025-26 rise to USD 774.98 bn compared to USD 721.2 bn recorded a year ago: Govt data.
-
India-UK FTA may come into force in May, Commerce Secretary Rajesh Agrawal tells reporters during briefing on trade data.
-
MS Dhoni Joins Forces with Cars24's Crashfree India Initiative
Google News